Lerman J A, Kaitin K I, Dement W C, Peroutka S J
Neurosci Lett. 1986 Dec 3;72(1):64-8. doi: 10.1016/0304-3940(86)90619-1.
Buspirone is a novel anxiolytic compound that does not produce the sedation often associated with the use of benzodiazepines. The present study evaluated the effects of this anxiolytic on sleep in rats surgically prepared for long-term recordings. Buspirone, at a dose of 3 mg/kg i.p., produced a significant increase in total wake time (P less than 0.05) compared with drug-free controls. At a dose of 10 mg/kg i.p., rats displayed altered sleep patterns with the most significant effects observed in the first third of recording period. These animals displayed increased wakefulness (P less than 0.001), decreased non-REM sleep (P less than 0.001), and an obliteration of REM sleep (P less than 0.02). These data support the suggestion that the clinically useful anxiolytic buspirone, unlike the benzodiazepines, does not induce sleep.
丁螺环酮是一种新型抗焦虑化合物,不会产生通常与使用苯二氮䓬类药物相关的镇静作用。本研究评估了这种抗焦虑药物对经过手术准备用于长期记录的大鼠睡眠的影响。腹腔注射剂量为3mg/kg的丁螺环酮,与未用药的对照组相比,总觉醒时间显著增加(P<0.05)。腹腔注射剂量为10mg/kg时,大鼠睡眠模式发生改变,在记录期的前三分之一观察到最显著的影响。这些动物表现出觉醒增加(P<0.001)、非快速眼动睡眠减少(P<0.001)和快速眼动睡眠消失(P<0.02)。这些数据支持了以下观点:临床上有用的抗焦虑药物丁螺环酮与苯二氮䓬类药物不同,不会诱导睡眠。